ConductScience.org, home

Paper42940323PubMed

Resveratrol Ameliorates Hyperuricemia in Association with Remodeling of the Gut Microbiota-Metabolism Axis: An Integrated 16S rDNA Sequencing and Fecal Metabolomics Study.

Wang Y and 7 others. Foods, 2026.

Cite this record

ConductScience Library. Resveratrol Ameliorates Hyperuricemia in Association with Remodeling of the Gut Microbiota-Metabolism Axis: An Integrated 16S rDNA Sequencing and Fecal Metabolomics Study. Papers, record 42940323. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42940323

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Resveratrol Ameliorates Hyperuricemia in Association with Remodeling of the Gut Microbiota-Metabolism Axis: An Integrated 16S rDNA Sequencing and Fecal Metabolomics Study.
Journal
Foods
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-28

Source PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YYan
2Xie JJing
3Cao ZZuoming
4Gao XXiaoyuhttps://orcid.org/0009-0003-1468-8184
5Yang ZZuoting
6Tian YYang
7Sheng JJun
8Peng LLeihttps://orcid.org/0000-0003-4315-4897

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
202501AT070150Yunnan Province Science and Technology DepartmentPubMed
202401AT070216Yunnan Province Science and Technology DepartmentPubMed
202505AV340010Yunnan Province Science and Technology DepartmentPubMed
2024J0512Yunnan Provincial Department of EducationPubMed
202603AS090006Yunnan Province Science and Technology DepartmentPubMed

Source PubMed

Download CSV of grants

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131263284Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.Nat Med2019https://conductscience.org/library/papers/31263284PubMed
228089200Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review.Clin Ther2017https://conductscience.org/library/papers/28089200PubMed
330531976Gut microbiome structure and metabolic activity in inflammatory bowel disease.Nat Microbiol2019https://conductscience.org/library/papers/30531976PubMed
441132832Bacteroi des fragilis-derived succinic acid promotes the degradation of uric acid by inhibiting hepatic AMPD2: Insight into how plant-based berberine ameliorates hyperuricemia.Acta Pharm Sin B2025https://conductscience.org/library/papers/41132832PubMed
533480266The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies.Crit Rev Food Sci Nutr2022https://conductscience.org/library/papers/33480266PubMed
632579811Effects of Allopurinol on the Progression of Chronic Kidney Disease.N Engl J Med2020https://conductscience.org/library/papers/32579811PubMed
78985016Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.Science1997https://conductscience.org/library/papers/8985016PubMed
822865646Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice.Mol Nutr Food Res2012https://conductscience.org/library/papers/22865646PubMed
936948133Protective effect of sodium butyrate on intestinal barrier damage and uric acid reduction in hyperuricemia mice.Biomed Pharmacother2023https://conductscience.org/library/papers/36948133PubMed
1032541923Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.Nat Rev Rheumatol2020https://conductscience.org/library/papers/32541923PubMed
1139874797Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products.Phytomedicine2025https://conductscience.org/library/papers/39874797PubMed
1233798500Gout.Lancet2021https://conductscience.org/library/papers/33798500PubMed
1340650188Influence of Gut Microbiota-Derived Butyrate on Intestinal Uric Acid Excretion and Hyperuricemia Regulation by Cichorium intybus L.Int J Mol Sci2025https://conductscience.org/library/papers/40650188PubMed
1434692558Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/34692558PubMed
1538088975A dynamics association study of gut barrier and microbiota in hyperuricemia.Front Microbiol2023https://conductscience.org/library/papers/38088975PubMed
1637478828Purine-ifying uric acid by gut microbes.Cell Chem Biol2023https://conductscience.org/library/papers/37478828PubMed
1739829115The Gut Microbiome in Hyperuricemia and Gout.Arthritis Rheumatol2025https://conductscience.org/library/papers/39829115PubMed
1832774692Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.Am J Transl Res2020https://conductscience.org/library/papers/32774692PubMed
1937279756Gut bacterial metabolism contributes to host global purine homeostasis.Cell Host Microbe2023https://conductscience.org/library/papers/37279756PubMed
2036034697Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/36034697PubMed

See all 67 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42940323

GET https://conductscience.org/api/papers/v1/42940323/references?page=2